SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jayashri Kulkarni, Emmy Gavrilidis, Roisin Worsley, Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 2016,

    CrossRef

  2. 2
    Andrea Gogos, Alyssa M. Sbisa, Jeehae Sun, Andrew Gibbons, Madhara Udawela, Brian Dean, A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings, International Journal of Endocrinology, 2015, 2015, 1

    CrossRef

  3. 3
    Andrea Gogos, Maarten van den Buuse, Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats, Schizophrenia Research, 2015, 168, 3, 634

    CrossRef

  4. 4
    Marie A. Labouesse, Wolfgang Langhans, Urs Meyer, Effects of selective estrogen receptor alpha and beta modulators on prepulse inhibition in male mice, Psychopharmacology, 2015, 232, 16, 2981

    CrossRef

  5. 5
    M. G. Cersosimo, E. E. Benarroch, Estrogen actions in the nervous system: Complexity and clinical implications, Neurology, 2015, 85, 3, 263

    CrossRef

  6. 6
    Katherine Sellers, Pooja Raval, Deepak P. Srivastava, Molecular signature of rapid estrogen regulation of synaptic connectivity and cognition, Frontiers in Neuroendocrinology, 2015, 36, 72

    CrossRef

  7. 7
    Agnès Lacreuse, Jessica A. Mong, Yuko Hara, Neurocognitive effects of estrogens across the adult lifespan in nonhuman primates: State of knowledge and new perspectives, Hormones and Behavior, 2015, 74, 157

    CrossRef

  8. 8
    Mélanie Bourque, Marc Morissette, Thérèse Di Paolo, Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1, Neuropharmacology, 2015, 95, 343

    CrossRef

  9. 9
    Claudia Barth, Arno Villringer, Julia Sacher, Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods, Frontiers in Neuroscience, 2015, 9,

    CrossRef

  10. 10
    Tertia D. Purves-Tyson, Danny Boerrigter, Katherine Allen, Katerina Zavitsanou, Tim Karl, Vanezha Djunaidi, Kay L. Double, Reena Desai, David J. Handelsman, Cynthia Shannon Weickert, Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats, Hormones and Behavior, 2015, 70, 73

    CrossRef

  11. 11
    Mary V. Seeman, Transient psychosis in women on clomiphene, bromocriptine, domperidone and related endocrine drugs, Gynecological Endocrinology, 2015, 31, 10, 751

    CrossRef

  12. 12
    Tsuyoshi Nakai, Taku Nagai, Rui Wang, Shinnosuke Yamada, Keisuke Kuroda, Kozo Kaibuchi, Kiyofumi Yamada, Alterations of GABAergic and dopaminergic systems in mutant mice with disruption of exons 2 and 3 of the Disc1 gene, Neurochemistry International, 2014, 74, 74

    CrossRef

  13. 13
    Shane J. Thwaites, Maarten van den Buuse, Andrea Gogos, Differential effects of estrogen and testosterone on auditory sensory gating in rats, Psychopharmacology, 2014, 231, 1, 243

    CrossRef

  14. 14
    Sean C. Godar, Marco Bortolato, Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission, Frontiers in Behavioral Neuroscience, 2014, 8,

    CrossRef

  15. 15
    Roberto Frau, Valentina Bini, Romina Pes, Giuliano Pillolla, Pierluigi Saba, Paola Devoto, Marco Bortolato, Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation, Psychoneuroendocrinology, 2014, 39, 204

    CrossRef

  16. 16
    Mélanie Bourque, Marc Morissette, Thérèse Di Paolo, Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice, Neurobiology of Aging, 2014, 35, 10, 2347

    CrossRef

  17. 17
    Andrea Gogos, YeeWen Candace Wu, Amy S. Williams, Linda K. Byrne, The Effects of Ethinylestradiol and Progestins (“the pill”) on Cognitive Function in Pre-menopausal Women, Neurochemical Research, 2014, 39, 12, 2288

    CrossRef

  18. 18
    Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi, Manuchair Ebadi, Biomarkers in Parkinson’s disease (recent update), Neurochemistry International, 2013, 63, 3, 201

    CrossRef

  19. 19
    Marie Bicikova, Martin Hill, Daniela Ripova, Pavel Mohr, Richard Hampl, Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia, The Journal of Steroid Biochemistry and Molecular Biology, 2013, 133, 77

    CrossRef

  20. 20
    Maria Gabriela Sánchez, Marc Morissette, Thérèse Di Paolo, Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2013, 45, 170

    CrossRef

  21. 21
    S. Al Sweidi, M. Morissette, C. Rouillard, T. Di Paolo, Estrogen receptors and lesion-induced response of striatal dopamine receptors, Neuroscience, 2013, 236, 99

    CrossRef

  22. 22
    Roberto Frau, Giuliano Pillolla, Valentina Bini, Simone Tambaro, Paola Devoto, Marco Bortolato, Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice, Psychoneuroendocrinology, 2013, 38, 4, 542

    CrossRef

  23. 23
    Martina Bonenberger, Rebecca C. Groschwitz, Daniela Kumpfmueller, Georg Groen, Paul L. Plener, Birgit Abler, It’s all about money, NeuroReport, 2013, 24, 17, 951

    CrossRef

  24. 24
    M. G. Sánchez, M. Morissette, T. Di Paolo, Oestradiol Modulation of Serotonin Reuptake Transporter and Serotonin Metabolism in the Brain of Monkeys, Journal of Neuroendocrinology, 2013, 25, 6
  25. 25
    C. Lemini, B. Cruz-López, L. Martínez-Mota, Participation of estrogen receptors in the antidepressant-like effect of prolame on the forced swimming test, Pharmacology Biochemistry and Behavior, 2013, 103, 3, 659

    CrossRef

  26. 26
    Y.C. Wu, R.A. Hill, A. Gogos, M. van den Buuse, Sex differences and the role of estrogen in animal models of schizophrenia: Interaction with BDNF, Neuroscience, 2013, 239, 67

    CrossRef

  27. 27
    M. Bortolato, R. Frau, S. C. Godar, L. J. Mosher, S. Paba, F. Marrosu, P. Devoto, The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α-Reductase?, Journal of Neuroendocrinology, 2013, 25, 11
  28. 28
    Maria Gabriela Sánchez, Marc Morissette, Thérèse Di Paolo, Effect of a chronic treatment with 17β-estradiol on striatal dopamine neurotransmission and the Akt/GSK3 signaling pathway in the brain of ovariectomized monkeys, Psychoneuroendocrinology, 2012, 37, 2, 280

    CrossRef

  29. 29
    Jayashri Kulkarni, Emily Hayes, Emmy Gavrilidis, Hormones and schizophrenia, Current Opinion in Psychiatry, 2012, 25, 2, 89

    CrossRef

  30. 30
    Q. David Walker, Misha L. Johnson, Amanda E.D. Van Swearingen, Andrew E. Arrant, Joseph M. Caster, Cynthia M. Kuhn, Individual differences in psychostimulant responses of female rats are associated with ovarian hormones and dopamine neuroanatomy, Neuropharmacology, 2012, 62, 7, 2267

    CrossRef

  31. 31
    S. Al Sweidi, M. G. Sánchez, M. Bourque, M. Morissette, D. Dluzen, T. Di Paolo, Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease, Journal of Neuroendocrinology, 2012, 24, 1
  32. 32
    Débora P. Maia, Patricia G. Fonseca, Sarah T. Camargos, Cláudia Pfannes, Mauro C. Cunningham, Francisco Cardoso, Pregnancy in patients with Sydenham’s Chorea, Parkinsonism & Related Disorders, 2012, 18, 5, 458

    CrossRef

  33. 33
    Jayashri Kulkarni, Emmy Gavrilidis, Roisin Worsley, Emily Hayes, Role of Estrogen Treatment in the Management of Schizophrenia, CNS Drugs, 2012, 26, 7, 549

    CrossRef

  34. 34
    Ignacio González-Burgos, Martha C. Rivera-Cervantes, Dulce A. Velázquez-Zamora, Alfredo Feria-Velasco, Luis Miguel Garcia-Segura, Selective Estrogen Receptor Modulators Regulate Dendritic Spine Plasticity in the Hippocampus of Male Rats, Neural Plasticity, 2012, 2012, 1

    CrossRef

  35. 35
    Mélanie Bourque, Dean E. Dluzen, Thérèse Di Paolo, Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease, Frontiers in Neuroendocrinology, 2012, 33, 2, 169

    CrossRef

  36. 36
    Jayashri Kulkarni, Emmy Gavrilidis, Emily Hayes, Victoria Heaton, Roisin Worsley, Special biological issues in the management of women with schizophrenia, Expert Review of Neurotherapeutics, 2012, 12, 7, 823

    CrossRef

  37. 37
    Andrea Gogos, Perrin Kwek, Maarten van den Buuse, The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia, Psychopharmacology, 2012, 219, 1, 213

    CrossRef

  38. 38
    Emily Hayes, Emorfia Gavrilidis, Jayashri Kulkarni, The Role of Oestrogen and Other Hormones in the Pathophysiology and Treatment of Schizophrenia, Schizophrenia Research and Treatment, 2012, 2012, 1

    CrossRef

  39. 39
    Pei Wang, Wei-Wei Tian, Jie Song, Yun-Feng Guan, Chao-Yu Miao, Deficiency of NG2+ Cells Contributes to the Susceptibility of Stroke-Prone Spontaneously Hypertensive Rats, CNS Neuroscience & Therapeutics, 2011, 17, 5
  40. 40
    Maria Gabriela Sánchez, Erika Estrada-Camarena, Nancy Bélanger, Marc Morissette, Thérèse Di Paolo, Estradiol modulation of cortical, striatal and raphe nucleus 5-HT1A and 5-HT2A receptors of female hemiparkinsonian monkeys after long-term ovariectomy, Neuropharmacology, 2011, 60, 4, 642

    CrossRef

  41. 41
    Sara Al-Sweidi, Marc Morissette, Mélanie Bourque, Thérèse Di Paolo, Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease, Neuropharmacology, 2011, 61, 4, 583

    CrossRef

  42. 42
    Adrianna Mendrek, Emmanuel Stip, Sexual dimorphism in schizophrenia: is there a need for gender-based protocols?, Expert Review of Neurotherapeutics, 2011, 11, 7, 951

    CrossRef

  43. 43
    S. A. Ivanova, A. V. Semke, O. Yu. Fedorenko, The correlation between schizophrenia duration and the serum concentration of dehydroepiandrosterone sulfate, Neurochemical Journal, 2011, 5, 4, 290

    CrossRef